380 related articles for article (PubMed ID: 29478609)
1. Neurogenetics of Pelizaeus-Merzbacher disease.
Osório MJ; Goldman SA
Handb Clin Neurol; 2018; 148():701-722. PubMed ID: 29478609
[TBL] [Abstract][Full Text] [Related]
2. Concise Review: Stem Cell-Based Treatment of Pelizaeus-Merzbacher Disease.
Osorio MJ; Rowitch DH; Tesar P; Wernig M; Windrem MS; Goldman SA
Stem Cells; 2017 Feb; 35(2):311-315. PubMed ID: 27882623
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
[TBL] [Abstract][Full Text] [Related]
4. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
[TBL] [Abstract][Full Text] [Related]
5. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene.
Lee ES; Moon HK; Park YH; Garbern J; Hobson GM
J Neurol Sci; 2004 Sep; 224(1-2):83-7. PubMed ID: 15450775
[TBL] [Abstract][Full Text] [Related]
6. Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.
Sima AA; Pierson CR; Woltjer RL; Hobson GM; Golden JA; Kupsky WJ; Schauer GM; Bird TD; Skoff RP; Garbern JY
Acta Neuropathol; 2009 Oct; 118(4):531-9. PubMed ID: 19562355
[TBL] [Abstract][Full Text] [Related]
7. Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.
Nevin ZS; Factor DC; Karl RT; Douvaras P; Laukka J; Windrem MS; Goldman SA; Fossati V; Hobson GM; Tesar PJ
Am J Hum Genet; 2017 Apr; 100(4):617-634. PubMed ID: 28366443
[TBL] [Abstract][Full Text] [Related]
8. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
Woodward KJ
Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
[TBL] [Abstract][Full Text] [Related]
9. Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
Laukka JJ; Kamholz J; Bessert D; Skoff RP
Neurosci Lett; 2016 Aug; 627():222-32. PubMed ID: 27222925
[TBL] [Abstract][Full Text] [Related]
10. A novel PLP1 frameshift mutation causing a milder form of Pelizaeus-Merzbacher disease.
Shiihara T; Watanabe M; Moriyama K; Uematsu M; Sameshima K
Brain Dev; 2015 Apr; 37(4):455-8. PubMed ID: 25043250
[TBL] [Abstract][Full Text] [Related]
11. Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.
Elitt MS; Tesar PJ
Trends Mol Med; 2024 May; 30(5):459-470. PubMed ID: 38582621
[TBL] [Abstract][Full Text] [Related]
12. Proteolipid protein 1 gene mutation in nine patients with Pelizaeus-Merzbacher disease.
Wang JM; Wu Y; Wang HF; Deng YH; Yang YL; Qin J; Li XY; Wu XR; Jiang YW
Chin Med J (Engl); 2008 Sep; 121(17):1638-42. PubMed ID: 19024090
[TBL] [Abstract][Full Text] [Related]
13. Pelizaeus-Merzbacher disease as a chromosomal disorder.
Yamamoto T; Shimojima K
Congenit Anom (Kyoto); 2013 Mar; 53(1):3-8. PubMed ID: 23480352
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the PLP1 gene residue p. Gly198 as the molecular basis of Pelizeaus-Merzbacher phenotype.
Hoffman-Zacharska D; Kmieć T; Poznański J; Jurek M; Bal J
Brain Dev; 2013 Oct; 35(9):877-80. PubMed ID: 23245814
[TBL] [Abstract][Full Text] [Related]
15. PLP1 gene duplication as a cause of the classic form of Pelizaeus-Merzbacher disease - case report.
Mądry J; Hoffman-Zacharska D; Królicki L; Jakuciński M; Friedman A
Neurol Neurochir Pol; 2010; 44(5):511-5. PubMed ID: 21082496
[TBL] [Abstract][Full Text] [Related]
16. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.
Inoue K
Neurogenetics; 2005 Feb; 6(1):1-16. PubMed ID: 15627202
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the Innate Immune Response by Human Neural Precursors Prevails over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model of Pelizaeus-Merzbacher Disease.
Marteyn A; Sarrazin N; Yan J; Bachelin C; Deboux C; Santin MD; Gressens P; Zujovic V; Baron-Van Evercooren A
Stem Cells; 2016 Apr; 34(4):984-96. PubMed ID: 26676415
[TBL] [Abstract][Full Text] [Related]
18. Clinical neurophysiology in GJA12-related hypomyelination vs Pelizaeus-Merzbacher disease.
Henneke M; Gegner S; Hahn A; Plecko-Startinig B; Weschke B; Gärtner J; Brockmann K
Neurology; 2010 Jun; 74(22):1785-9. PubMed ID: 20513814
[TBL] [Abstract][Full Text] [Related]
19. Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.
Lossos A; Elazar N; Lerer I; Schueler-Furman O; Fellig Y; Glick B; Zimmerman BE; Azulay H; Dotan S; Goldberg S; Gomori JM; Ponger P; Newman JP; Marreed H; Steck AJ; Schaeren-Wiemers N; Mor N; Harel M; Geiger T; Eshed-Eisenbach Y; Meiner V; Peles E
Brain; 2015 Sep; 138(Pt 9):2521-36. PubMed ID: 26179919
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional study of novel PLP1 mutations in Chinese patients with Pelizaeus-Merzbacher disease.
Xie H; Feng H; Ji J; Wu Y; Kou L; Li D; Ji H; Wu X; Niu Z; Wang J; Jiang Y
Brain Dev; 2015 Sep; 37(8):797-802. PubMed ID: 25491635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
